ACADIA Pharmaceuticals (ACAD) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ACAD is expected to report earnings to fall 37.15% to 12 cents per share on October 31

ACADIA Pharmaceuticals ACAD Stock Earnings Reports

Q3'24

Est.

$0.13

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.05

Q4'23

Missed

by $0.01

Q3'23

Beat

by $0.05

The last earnings report on August 06 showed earnings per share of 20 cents, beating the estimate of 18 cents. With 1.99M shares outstanding, the current market capitalization sits at 2.60B.

View a ticker or compare two or three

Compare

ACAD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ACAD
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ACAD (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of pharmaceuticals drugs for treatment of central nervous system disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12830 El Camino Real

Phone

+1 858 558-2871

Employees

598

Web

https://www.acadia.com